Prescription drug · NDA
Retevmo (Selpercatinib) NDC 0002-2980
Selpercatinib 80 mg/1 · Capsule · Oral · Eli Lilly and Company
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0002-2980-26 | 00002298026 | 120 CAPSULE in 1 BOTTLE (0002-2980-26)Marketed from May 8, 2020 | |
| 0002-2980-60 | 00002298060 | 60 CAPSULE in 1 BOTTLE (0002-2980-60)Marketed from May 8, 2020 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Retevmo
- Generic name (nonproprietary)
- selpercatinib
- Active ingredients
- Selpercatinib — 80 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Eli Lilly and CompanyNDC labeler code 0002
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 213246
- Marketing start
- Listing expires
- Other FDA classes
- Breast Cancer Resistance Protein Inhibitors (Mechanism)Cytochrome P450 2C8 Inhibitors (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Multidrug and Toxin Extrusion Transporter 1 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)Rearranged during Transfection (RET) Inhibitors (Mechanism)
- Identifiers
- Product ID 0002-2980_7481a510-805c-4f99-b6ae-7b44e70f5f55SPL ID 7481a510-805c-4f99-b6ae-7b44e70f5f55
- Pharmacologic class
- Kinase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400002298026followed by a unit qualifier and the quantityPackage 00002-2980-26. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 0002-2980
- What is NDC 0002-2980?
- 0002-2980 is the product NDC for Retevmo (selpercatinib), Selpercatinib 80 mg/1 capsule, listed with the FDA by Eli Lilly and Company. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Retevmo (Selpercatinib).
- What is the active ingredient?
- Selpercatinib.
- Who is the labeler?
- Eli Lilly and Company, NDC labeler code 0002. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Retevmo?
- 5 other product NDCs are listed under this name. See all Retevmo NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Retevmo products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Retevmoselpercatinib | Selpercatinib 160 mg/1 | Tablet, CoatedOral | Eli Lilly and Company | 0002-5562 | 00002-5562-60 |
| Retevmoselpercatinib | Selpercatinib 120 mg/1 | Tablet, CoatedOral | Eli Lilly and Company | 0002-6120 | 00002-6120-60 |
| Retevmoselpercatinib | Selpercatinib 40 mg/1 | Tablet, CoatedOral | Eli Lilly and Company | 0002-5340 | 00002-5340-60 |
| Retevmoselpercatinib | Selpercatinib 80 mg/1 | Tablet, CoatedOral | Eli Lilly and Company | 0002-6082 | 00002-6082-60 |
| Retevmoselpercatinib | Selpercatinib 40 mg/1 | CapsuleOral | Eli Lilly and Company | 0002-3977 | 00002-3977-60 |
Other NDCs under NDA 213246
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Retevmoselpercatinib | Selpercatinib 40 mg/1 | CapsuleOral | Eli Lilly and Company | 0002-3977 |